The main findings of this retrospective cohort study, based on long-term follow-up, are as follows: firstly, to the best of our knowledge, this study is the first to use AST/ALT ratio to assess outcomes in stable CAD patients. This evidence concerns the gene GPT and coronary artery disorder.